208 related articles for article (PubMed ID: 26149987)
1. Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.
Abuhelwa AY; Foster DJ; Mudge S; Hayes D; Upton RN
Antimicrob Agents Chemother; 2015 Sep; 59(9):5681-96. PubMed ID: 26149987
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.
Abuhelwa AY; Mudge S; Upton RN; Foster DJR
Eur J Drug Metab Pharmacokinet; 2019 Apr; 44(2):201-215. PubMed ID: 30328059
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
[TBL] [Abstract][Full Text] [Related]
4. Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects.
Lindsay J; Mudge S; Thompson GR
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297369
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and Relative Bioavailability of Orally Administered Innovator-Formulated Itraconazole Capsules and Solution in Healthy Dogs.
Hasbach AE; Langlois DK; Rosser EJ; Papich MG
J Vet Intern Med; 2017 Jul; 31(4):1163-1169. PubMed ID: 28627123
[TBL] [Abstract][Full Text] [Related]
6. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers.
Woo JS; Song YK; Hong JY; Lim SJ; Kim CK
Eur J Pharm Sci; 2008 Feb; 33(2):159-65. PubMed ID: 18178070
[TBL] [Abstract][Full Text] [Related]
7. Food interaction and steady-state pharmacokinetics of itraconazole oral solution in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Pharmacotherapy; 1998; 18(2):295-301. PubMed ID: 9545149
[TBL] [Abstract][Full Text] [Related]
8. Enhanced bioavailability of itraconazole in hydroxypropyl-beta-cyclodextrin solution versus capsules in healthy volunteers.
Barone JA; Moskovitz BL; Guarnieri J; Hassell AE; Colaizzi JL; Bierman RH; Jessen L
Antimicrob Agents Chemother; 1998 Jul; 42(7):1862-5. PubMed ID: 9661037
[TBL] [Abstract][Full Text] [Related]
9. Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole.
Abuhelwa AY; Mudge S; Upton RN; Foster DJR
J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):181-197. PubMed ID: 29150770
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of Single-Dose SUBA-Itraconazole Compared to Conventional Itraconazole under Fasted and Fed Conditions.
Rauseo AM; Mazi P; Lewis P; Burnett B; Mudge S; Spec A
Antimicrob Agents Chemother; 2021 Jul; 65(8):e0013421. PubMed ID: 34031053
[TBL] [Abstract][Full Text] [Related]
11. Comparison of absorption characteristics of oral reference and compounded itraconazole formulations in healthy cats.
Mawby DI; Whittemore JC; Fowler LE; Papich MG
J Am Vet Med Assoc; 2018 Jan; 252(2):195-200. PubMed ID: 29319446
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
Zhou H; Goldman M; Wu J; Woestenborghs R; Hassell AE; Lee P; Baruch A; Pesco-Koplowitz L; Borum J; Wheat LJ
J Clin Pharmacol; 1998 Jul; 38(7):593-602. PubMed ID: 9702843
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.
Mouton JW; van Peer A; de Beule K; Van Vliet A; Donnelly JP; Soons PA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4096-102. PubMed ID: 16982783
[TBL] [Abstract][Full Text] [Related]
14. A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.
Hennig S; Waterhouse TH; Bell SC; France M; Wainwright CE; Miller H; Charles BG; Duffull SB
Br J Clin Pharmacol; 2007 Apr; 63(4):438-50. PubMed ID: 17073891
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons.
Koks CH; Huitema AD; Kroon ED; Chuenyam T; Sparidans RW; Lange JM; Beijnen JH
Ther Drug Monit; 2003 Apr; 25(2):229-33. PubMed ID: 12657919
[TBL] [Abstract][Full Text] [Related]
16. Increased oral bioavailability of itraconazole and its active metabolite, 7-hydroxyitraconazole, when coadministered with a vitamin C beverage in healthy participants.
Bae SK; Park SJ; Shim EJ; Mun JH; Kim EY; Shin JG; Shon JH
J Clin Pharmacol; 2011 Mar; 51(3):444-51. PubMed ID: 20400647
[No Abstract] [Full Text] [Related]
17. Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug.
Abuhelwa AY; Mudge S; Hayes D; Upton RN; Foster DJ
Pharm Res; 2016 Jul; 33(7):1782-94. PubMed ID: 27119846
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the effects of rice and bread meals on bioavailability of itraconazole using NONMEM in healthy volunteers.
Yun HY; Baek MS; Park IS; Choi BK; Kwon KI
Eur J Clin Pharmacol; 2006 Dec; 62(12):1033-9. PubMed ID: 17053894
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of oral itraconazole administration in captive Humboldt penguins (Spheniscus humboldti).
Bunting EM; Abou-Madi N; Cox S; Martin-Jimenez T; Fox H; Kollias GV
J Zoo Wildl Med; 2009 Sep; 40(3):508-18. PubMed ID: 19746867
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
